Zai Lab Limited Total Non Current Liabilities 2011-2026 | ZLAB

Annual Total Non Current Liabilities Zai Lab Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	13.9 M	2.06 M	2.39 M	135 M	28.4 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
135 M	2.06 M	36.4 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Regeneron Pharmaceuticals REGN	1.62 B	$ 742.1	-1.93 %	$ 77.6 B	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	81.7 B	$ 211.9	0.37 %	$ 375 B	USA
Replimune Group REPL	38.5 M	$ 7.26	-3.71 %	$ 585 M	USA
AbCellera Biologics ABCL	326 M	$ 3.28	-2.24 %	$ 980 M	Canada
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Rigel Pharmaceuticals RIGL	35.5 M	$ 26.28	-0.34 %	$ 473 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Avidity Biosciences RNA	152 M	$ 13.07	-0.23 %	$ 1.8 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Rhythm Pharmaceuticals RYTM	3.09 M	$ 77.56	-5.31 %	$ 5.04 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	263 M	$ 12.27	-12.11 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	9.05 M	$ 5.36	7.96 %	$ 383 M	USA
Silence Therapeutics plc SLN	51.3 M	$ 4.92	-7.34 %	$ 622 M	Britain
SELLAS Life Sciences Group SLS	825 K	$ 4.47	-9.69 %	$ 487 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	299 K	$ 1.08	-1.38 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	425 K	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	5.71 M	$ 16.59	-3.88 %	$ 12.4 B	Britain
Spruce Biosciences SPRB	31 M	$ 62.07	-10.19 %	$ 47.6 M	USA